Slide 1 Fecal Microbiota for Transplantation Jay E. Slater, MD FDA/CBER/OVRR/DBPAP Slide 2 2/30 Outline Why does FDA regulate fecal microbiota for transplantation? When is…

Slide 1 Prevnar 13 for Adult Use Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM 197 Protein) Applicant: Wyeth Pharmaceuticals, Inc Nicolette deVore, Ph.D. Regulatory…

Slide 1 Measurements of ‘Patient Centred Care’ in Anaesthesia Dr. Sujesh Bansal Consultant Anaesthetist 18 th May 2015 Slide 2 Why? What do we mean by – Measure of…

Slide 1 Fulfilling the Promise of Medicine Together Preparing for an IDE Application John McLane, Ph.D. COO & Vice President Clinical and Regulatory Affairs Clinquest,…

Slide 1 Low Cost Safety Improvements Pooled Fund Study (PFS) presented by Kim Eccles, P.E. Senior Engineer, VHB Slide 2 Low Cost Safety Improvements PFS Background AASHTO’s…

Slide 1 Nina Cohen, PhD Science Policy Officer Research & Toxicology Department Horizon 2020 Advancing Safety Science and Health Research with Modern, Non-Animal Tools…

Project Kickoff Sonali Muzumdar Pharm.D., CPHIMS Informatics Pharmacist Mercy Hospital and Medical Center Comprehensive Pharmacy Services Leveraging Rules and Alerts to Improve…

(NEW DRUG APPLICATION) R.MEENAKSHI M Pharm (Pharm. Chemistry) R.MEENAKSHI M.PHARM(Chemistry),2010 CONTENTS HISTORY INTRODUCTION APPLICATION FORM IND REVIEW PROCESS NDA REVIEW…

Slide 1 1 New Strategies for Using Advanced Technology and Care Models for Safer, More Effective, More Humane Health Services No One Grows Old Saying, “Gee, I Hope I End…

Low Cost Safety Improvements Pooled Funds Study Increasing Retroreflectivity of STOP Signs Results Dr. Bhagwant Persaud, Persaud and Lyon, Inc Overview Introduction Objective…